Metraipolis › archive › dc_e2becfb36163
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective — Europe PMC PMID:41492631
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41492631
- DOI
- 10.7759/cureus.98476
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:10:53.295Z
- SHA-256 of the archived text
10f82caa3e515907ddf172b75ae88de1ad784c3ea8f0e38f429b781f9c561fc5- Stable URL of this page
https://metraipolis.com/documento/dc_e2becfb36163
How to cite
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective — Europe PMC PMID:41492631 — Europe PMC (en), https://europepmc.org/article/MED/41492631 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2becfb36163 (Metraipolis archive dc_e2becfb36163, sha256 10f82caa3e515907ddf172b75ae88de1ad784c3ea8f0e38f429b781f9c561fc5)
BibTeX
@misc{dce2becfb36163,
title = {Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective — Europe PMC PMID:41492631},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41492631},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2becfb36163; sha256 10f82caa3e515907ddf172b75ae88de1ad784c3ea8f0e38f429b781f9c561fc5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41492631. Agents can read the archived copy with the MCP tool read_document.